Mckesson Medical-Surgical Inc. Corporate Office recalls Dihydroergotamine Mesylate, Injection, USP, 1mg/mL, packaged in box of 5 x 1 mL ampules, Rx only, Manufactured for: Perr
Recalled June 15, 2022 · FDA recall D-1011-2022 · Mckesson Medical-Surgical Inc. Corporate Office
Hazard
cGMP deviations: Temperature abuse · FDA Class II
Units
1 carton
Sold at
USA nationwide.
Description
cGMP deviations: Temperature abuse
Product
Dihydroergotamine Mesylate, Injection, USP, 1mg/mL, packaged in box of 5 x 1 mL ampules, Rx only, Manufactured for: Perrigo, Minneapolis, MN, NDC 0574-0850-10
Manufacturer(s)
Mckesson Medical-Surgical Inc. Corporate Office
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →